Analysis of polycystic ovary syndrome and infertility using PRISMA 2020 literature review
DOI:
https://doi.org/10.56294/dm2024.239Keywords:
infertility, polycystic ovary syndrome, insulin resistance, chronic inflammation, emerging treatmentsAbstract
Polycystic ovary syndrome (PCOS) is a complex endocrine and metabolic condition that significantly affects the fertility of women of reproductive age. The aim of the study was to analyze polycystic ovary syndrome and its impact on infertility through a PRISMA 2020 literature review. A systematic search was conducted in PubMed using MeSH terms related to PCOS and infertility, covering publications from 2018 to 2024. Original articles, systematic reviews, and relevant meta-analyses were included, while duplicate studies or those with insufficient methodological quality were excluded. The results showed that hyperandrogenism, insulin resistance, and chronic inflammation are key mechanisms affecting ovulation and endometrial quality, contributing to infertility. Lifestyle modifications, such as diet and exercise, are identified as the first line of treatment, while emerging therapies like resveratrol, probiotics, and traditional Chinese medicine offer promising options. Additionally, relevant relationships between PCOS and comorbidities such as thyroid diseases and osteoporosis are observed, expanding its systemic impact. Despite advances in therapies and pathophysiological understanding, challenges persist due to the lack of classification between genotypes and clinical phenotypes. It is concluded that the management of PCOS should be comprehensive and personalized, integrating innovative and multidisciplinary strategies to improve patients' quality of life and reproductive outcomes. This study provides a solid foundation to guide future research and optimize clinical practice
References
1. Di Lorenzo M, Cacciapuoti N, Lonardo MS, Nasti G, Gautiero C, Belfiore A, Guida B, Chiurazzi M. Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review. Curr Nutr Rep. 2023 Sep;12(3):527-544. doi: 10.1007/s13668-023-00479-8
2. Dong J, Rees DA. Polycystic ovary syndrome: pathophysiology and therapeutic opportunities. BMJ Med. 2023 Oct 12;2(1):e000548. doi: 10.1136/bmjmed-2023-000548.
3. Kulkarni S, Gupta K, Ratre P, Mishra PK, Singh Y, Biharee A, Thareja S. Polycystic ovary syndrome: Current scenario and future insights. Drug Discov Today. 2023 Dec;28(12):103821. doi: 10.1016/j.drudis.2023.103821.
4. Wang K, Li Y. Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome. Front Endocrinol (Lausanne). 2023 Oct 19;14:1191759. doi: 10.3389/fendo.2023.1191759.
5. Shrivastava S, Conigliaro RL. Polycystic Ovarian Syndrome. Med Clin North Am. 2023 Mar;107(2):227-234. doi: 10.1016/j.mcna.2022.10.004.
6. Chen H, Deng C, Meng Z, Meng S. Effects of TCM on polycystic ovary syndrome and its cellular endocrine mechanism. Front Endocrinol (Lausanne). 2023 May 16;14:956772. doi: 10.3389/fendo.2023.956772.
7. Calcaterra V, Rossi V, Massini G, Casini F, Zuccotti G, Fabiano V. Probiotics and Polycystic Ovary Syndrome: A Perspective for Management in Adolescents with Obesity. Nutrients. 2023 Jul 14;15(14):3144. doi: 10.3390/nu15143144.
8. Stańczak NA, Grywalska E, Dudzińska E. The latest reports and treatment methods on polycystic ovary syndrome. Ann Med. 2024 Dec;56(1):2357737. doi: 10.1080/07853890.2024.2357737.
9. Fan H, Ren Q, Sheng Z, Deng G, Li L. The role of the thyroid in polycystic ovary syndrome. Front Endocrinol (Lausanne). 2023 Oct 5;14:1242050. doi: 10.3389/fendo.2023.1242050.
10. Saleh FL, Starkman H, Furness A, Pfeifer SM, Kives S. Polycystic Ovary Syndrome in Adolescents. Obstet Gynecol Clin North Am. 2024 Dec;51(4):679-693. doi: 10.1016/j.ogc.2024.08.005.
11. Sudhakaran G, Priya PS, Jagan K, Haridevamuthu B, Meenatchi R, Arockiaraj J. Osteoporosis in polycystic ovary syndrome (PCOS) and involved mechanisms. Life Sci. 2023 Dec 15;335:122280. doi: 10.1016/j.lfs.2023.122280.
12. Ali Fadlalmola H, Elhusein AM, Al-Sayaghi KM, Albadrani MS, Swamy DV, Mamanao DM, El-Amin EI, Ibrahim SE, Abbas SM. Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials. Pan Afr Med J. 2023 Mar 16;44:134. doi: 10.11604/pamj.2023.44.134.32404.
13. Colombo GE, Pirotta S, Sabag A. Diet and Exercise in the Management of Polycystic Ovary Syndrome: Practical Considerations for Person-Centered Care. Semin Reprod Med. 2023 Mar;41(1-02):26-36. doi: 10.1055/s-0043-1777116.
14. Haddad-Filho H, Tosatti JAG, Vale FM, Gomes KB, Reis FM. Updates in diagnosing polycystic ovary syndrome-related infertility. Expert Rev Mol Diagn. 2023 Feb;23(2):123-132. doi: 10.1080/14737159.2023.2177536.
15. González Chico MG, Hernández Bandera N, Herrera Lazo S, Laica Sailema N. Assessment of the Relevance of Intercultural Medical Care. Neutrosophic sampling. Neutrosophic Sets and Systems. 2021;44(1). Disponible en: https://digitalrepository.unm.edu/nss_journal/vol44/iss1/46
16. Estupiñán-Ricardo J, Leyva-Vázquez M, Álvarez-Gómez S, Alfonso-Manzanet J, Velázquez-Soto O, Rodríguez---Guzmán A. La aplicación de la neutrosofía en las ciencias médicas: una revisión bibliográfica narrativa. Revista Cubana de Información en Ciencias de la Salud [Internet]. 2023 [citado 14 Feb 2024]; 34 Disponible en: https://acimed.sld.cu/index.php/acimed/article/view/2599
17. Álvarez Gómez ME, Méndez Cabrita M, Coka Flores DF, Rodríguez Reyes CG. Neutrosociology for Analyzing Public Procurement in Ecuador around the Health Emergency. Neutrosophic Sets and Systems. 2021;44(1). Disponible en: https://digitalrepository.unm.edu/nss_journal/vol44/iss1/37.
Published
Issue
Section
License
Copyright (c) 2024 Sylvia del Pilar Núñez Arroba , Liliana Katherine Sailema López, Génesis Alexandra Zúñiga Cárdenas (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
